MedPath

Hebrew University of Jerusalem

🇺🇸United States
Ownership
-
Established
1918-01-01
Employees
1.2K
Market Cap
-
Website
https://new.huji.ac.il/

Clinical Trials

31

Active:1
Completed:14

Trial Phases

4 Phases

Phase 1:1
Phase 2:1
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials

Not Applicable
25 (89.3%)
Phase 1
1 (3.6%)
Phase 2
1 (3.6%)
Phase 3
1 (3.6%)

Evaluation of the Social ABCs in Israel

Not Applicable
Completed
Conditions
Autism
Autism Spectrum Disorder (ASD)
First Posted Date
2025-06-17
Last Posted Date
2025-06-17
Lead Sponsor
Hebrew University of Jerusalem
Target Recruit Count
20
Registration Number
NCT07025603
Locations
🇮🇱

Soroka Medical Center, Beer-Sheva, Israel

🇮🇱

Hebrew University of Jerusalem, Jerusalem, Israel

A Study to Test Feasibility and Acceptability of an Intervention Program Aiming to Reduce Prenatal Secondhand Smoke Exposure

Not Applicable
Recruiting
Conditions
Secondhand Smoke Exposure
First Posted Date
2025-06-04
Last Posted Date
2025-06-04
Lead Sponsor
Hebrew University of Jerusalem
Target Recruit Count
160
Registration Number
NCT07003282
Locations
🇮🇱

Braun School of Public Health and Community Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

Testing the Cog-Fun Aging Program for Older Adults with Subjective Cognitive Decline

Not Applicable
Recruiting
Conditions
Subjective Cognitive Decline (SCD)
Subjective Cognitive Impairment
Subjective Memory Complaints
First Posted Date
2025-02-10
Last Posted Date
2025-02-12
Lead Sponsor
Hebrew University of Jerusalem
Target Recruit Count
40
Registration Number
NCT06816797
Locations
🇮🇱

Hebrew University of Jerusalem, Jerusalem, Israel

🇮🇱

Merhavim Misgav, Misgav, Israel

🇮🇱

Hadarim College, Sde Warburg, Israel

The Effectiveness of Cognitive-Functional Remote Group Intervention (Cog-Fun RG) for Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Not Applicable
Recruiting
Conditions
ADHD
First Posted Date
2024-10-14
Last Posted Date
2024-10-14
Lead Sponsor
Hebrew University of Jerusalem
Target Recruit Count
40
Registration Number
NCT06639139
Locations
🇮🇱

Hebrew University, Jerusalem, Israel

Cognitive Control Mechanisms in Older Adults

Not Applicable
Recruiting
Conditions
Depressive Symptoms
First Posted Date
2024-10-08
Last Posted Date
2024-10-08
Lead Sponsor
Hebrew University of Jerusalem
Target Recruit Count
42
Registration Number
NCT06631781
Locations
🇮🇱

Computerized Neurotherapy Lab, School of OT, Hebrew University, Mt. Scopus Campus, Jerusalem, Israel

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

Hebrew University Develops Revolutionary XHA-Based Antibiotic Eyedrops with Potential for Human Applications

Israeli researchers at Hebrew University have developed a novel antibiotic eyedrop formulation using cross-linked hyaluronic acid (XHA) that significantly improves drug retention and efficacy compared to conventional carriers.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.